These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27128373)

  • 41. The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.
    Shinohara M; Sato N
    Adv Exp Med Biol; 2019; 1128():85-101. PubMed ID: 31062326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol.
    Michikawa M
    Mol Neurobiol; 2003 Feb; 27(1):1-12. PubMed ID: 12668899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of cholesterol in Alzheimer's neuro-pathogenesis].
    Biondi E
    Riv Biol; 2006; 99(2):210-5. PubMed ID: 17115369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.
    Fonteh AN; Ormseth C; Chiang J; Cipolla M; Arakaki X; Harrington MG
    PLoS One; 2015; 10(5):e0125597. PubMed ID: 25938590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's disease: brain expression of a metabolic disorder?
    Merlo S; Spampinato S; Canonico PL; Copani A; Sortino MA
    Trends Endocrinol Metab; 2010 Sep; 21(9):537-44. PubMed ID: 20541952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High carbohydrate diets and Alzheimer's disease.
    Henderson ST
    Med Hypotheses; 2004; 62(5):689-700. PubMed ID: 15082091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipids as key players in Alzheimer disease: alterations in metabolism and genetics.
    Sagin FG; Sozmen EY
    Curr Alzheimer Res; 2008 Feb; 5(1):4-14. PubMed ID: 18288926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.
    Yu JT; Tan L
    Mol Neurobiol; 2012 Apr; 45(2):314-26. PubMed ID: 22274961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.
    Martins IJ; Berger T; Sharman MJ; Verdile G; Fuller SJ; Martins RN
    J Neurochem; 2009 Dec; 111(6):1275-308. PubMed ID: 20050287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipids and Alzheimer's disease.
    Garner B
    Biochim Biophys Acta; 2010 Aug; 1801(8):747-9. PubMed ID: 20547302
    [No Abstract]   [Full Text] [Related]  

  • 53. Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.
    Bascoul-Colombo C; Guschina IA; Maskrey BH; Good M; O'Donnell VB; Harwood JL
    Biochim Biophys Acta; 2016 Jun; 1861(6):524-37. PubMed ID: 26968097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloid beta-protein and lipid metabolism.
    Zinser EG; Hartmann T; Grimm MO
    Biochim Biophys Acta; 2007 Aug; 1768(8):1991-2001. PubMed ID: 17418089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding the function of ABCA7 in Alzheimer's disease.
    Li H; Karl T; Garner B
    Biochem Soc Trans; 2015 Oct; 43(5):920-3. PubMed ID: 26517904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
    Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
    Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
    Díaz M; Fabelo N; Casañas-Sánchez V; Marin R; Gómez T; Quinto-Alemany D; Pérez JA
    J Alzheimers Dis; 2016; 49(2):459-81. PubMed ID: 26519437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.